Bipolar Disorder
... Although bipolar disorder represents a major public health problem, its causes remain incompletely understood. It is now clear that genetic factors play a significant role in the onset of bipolar disorder, as recent studies suggest a heritability risk of 85%.5 Moreover, not only is bipolar disorder ...
... Although bipolar disorder represents a major public health problem, its causes remain incompletely understood. It is now clear that genetic factors play a significant role in the onset of bipolar disorder, as recent studies suggest a heritability risk of 85%.5 Moreover, not only is bipolar disorder ...
Atlas of Bipolar Disorders
... Throughout recorded history there have been descriptions of people with symptoms resembling bipolar illness. This is particularly true for depressive episodes. Stories depicting manic and depressive episodes can be found in ancient Greek, Persian, and biblical writings. Areteus in the second century ...
... Throughout recorded history there have been descriptions of people with symptoms resembling bipolar illness. This is particularly true for depressive episodes. Stories depicting manic and depressive episodes can be found in ancient Greek, Persian, and biblical writings. Areteus in the second century ...
Webinar Presentation - PPT - Resources for Integrated Care
... from substitution because of the potential negative consequences ■ Switching might be associated with increased use of AED and non-AED medications, and health care resources (including hospitalization) ...
... from substitution because of the potential negative consequences ■ Switching might be associated with increased use of AED and non-AED medications, and health care resources (including hospitalization) ...
Consensus paper on bipolar depression
... Bipolar depression in children: Bipolar I disorder is rare in prepubertal children, when defined according to unmodified DSM-IV-TR criteria. A broad diagnosis of bipolar disorder risks confounding with other childhood psychopathology and has less predictive value for bipolar disorder in adulthood th ...
... Bipolar depression in children: Bipolar I disorder is rare in prepubertal children, when defined according to unmodified DSM-IV-TR criteria. A broad diagnosis of bipolar disorder risks confounding with other childhood psychopathology and has less predictive value for bipolar disorder in adulthood th ...
Understanding Bipolar Disorder and Recovery What you
... Another type of bipolar disorder, cyclothymia, refers to a more chronic unstable mood state. This diagnosis is given when, over the course of one year for children and adolescents, or two years for an adult, a person experiences moods that are abnormally high or low for at least half of the days. Du ...
... Another type of bipolar disorder, cyclothymia, refers to a more chronic unstable mood state. This diagnosis is given when, over the course of one year for children and adolescents, or two years for an adult, a person experiences moods that are abnormally high or low for at least half of the days. Du ...
The World Federation of Societies of Biological Psychiatry (WFSBP
... This practice guideline for the biological, mainly pharmacological treatment of acute bipolar depression was developed by an international Task Force of the World Federation of Societies of Biological Psychiatry (WFSBP) and is part of a series covering the acute treatment of mania, bipolar depressio ...
... This practice guideline for the biological, mainly pharmacological treatment of acute bipolar depression was developed by an international Task Force of the World Federation of Societies of Biological Psychiatry (WFSBP) and is part of a series covering the acute treatment of mania, bipolar depressio ...
Evidence-based guidelines for treating bipolar disorder: revised second —recommendations edition
... knowledge that efficacy of treatment choice has been established against placebo or other relevant comparator. It does not mean practice dominated by evidence that one effective treatment is definitely better than the other. The key to success is cautious prescribing of adequate doses and monitoring ...
... knowledge that efficacy of treatment choice has been established against placebo or other relevant comparator. It does not mean practice dominated by evidence that one effective treatment is definitely better than the other. The key to success is cautious prescribing of adequate doses and monitoring ...
Durand and Barlow Chapter 12: Schizophrenia and Other Psychotic
... – May activate underlying vulnerability and/or increase risk of relapse ...
... – May activate underlying vulnerability and/or increase risk of relapse ...
Chapter 12
... Marked disruptions in speech and behavior, flat or inappropriate affect Hallucinations and delusions have a theme, but tend to be fragmented This type develops early, tends to be chronic, lacks periods of remissions ...
... Marked disruptions in speech and behavior, flat or inappropriate affect Hallucinations and delusions have a theme, but tend to be fragmented This type develops early, tends to be chronic, lacks periods of remissions ...
I`m Bipolar, You`re Bipolar - Law Project for Psychiatric Rights
... In the case of bipolar disorder, this conceptual gerrymandering has involved stretching and diluting the definition of what used to be called manic-depressive illness so that it might include depression and other mood disorders, thus creating a market for “atypical” antipsychotic medications such as ...
... In the case of bipolar disorder, this conceptual gerrymandering has involved stretching and diluting the definition of what used to be called manic-depressive illness so that it might include depression and other mood disorders, thus creating a market for “atypical” antipsychotic medications such as ...
Interactions between the cytochrome P450 system and
... Awareness of the metabolism of second-generation antipsychotics by the cytochrome P450 (CYP) system can inform the clinician about how to avoid and manage drug–drug interactions involving these enzymes. Clozapine is metabolized primarily by CYP1A2, with additional contributions by CYP2C19, CYP2D6 an ...
... Awareness of the metabolism of second-generation antipsychotics by the cytochrome P450 (CYP) system can inform the clinician about how to avoid and manage drug–drug interactions involving these enzymes. Clozapine is metabolized primarily by CYP1A2, with additional contributions by CYP2C19, CYP2D6 an ...
Mood Spectrum Disorders
... these individuals often feel a lack of energy, a need to stay in bed or get extra sleep, and little or no motivation to do things they need to do______ . They often put on weight during these periods______ . During their low phases, these individuals often feel "blue," sad all the time, or depressed ...
... these individuals often feel a lack of energy, a need to stay in bed or get extra sleep, and little or no motivation to do things they need to do______ . They often put on weight during these periods______ . During their low phases, these individuals often feel "blue," sad all the time, or depressed ...
CHILDHOOD SCHIZOPHRENIA
... preliminary results showed the presence of brain abnormalities in temporolimbic areas in patients with early-onset schizophrenia. These abnormalities are similar to those seen in adult schizophrenia. Several studies (psychological, pharmacologic, and neuroimaging) of childhood-onset schizophrenia ha ...
... preliminary results showed the presence of brain abnormalities in temporolimbic areas in patients with early-onset schizophrenia. These abnormalities are similar to those seen in adult schizophrenia. Several studies (psychological, pharmacologic, and neuroimaging) of childhood-onset schizophrenia ha ...
Recognizing and Treating Bipolar Disorder
... of bipolar spectrum disorders.2,6 In the past, bipolar disorder was thought to be relatively rare as compared to unipolar depression. It is well documented that major depression is a common condition, with a lifetime prevalence of 21.3% for females and 12.7% for males in the United States.12 The DSM ...
... of bipolar spectrum disorders.2,6 In the past, bipolar disorder was thought to be relatively rare as compared to unipolar depression. It is well documented that major depression is a common condition, with a lifetime prevalence of 21.3% for females and 12.7% for males in the United States.12 The DSM ...
Pediatric Bipolar Disorder
... mom’s attempts to set limits at home Mood changes occur mostly in response to frustrations There are not any hallmark symptoms of grandiosity, euphoria, hypersexuality No history of days-long episodes He is very young to diagnose as bipolar ...
... mom’s attempts to set limits at home Mood changes occur mostly in response to frustrations There are not any hallmark symptoms of grandiosity, euphoria, hypersexuality No history of days-long episodes He is very young to diagnose as bipolar ...
Treatment of Behavioural and Psychological Symptoms in Dementia
... minor damage in these areas can cause dementia, but also larger impairments in other parts of the brain can lead to dementia (3). Dementia can be divided in three main groups by it's cause: I) primary degenerative dementia II)vascular dementia III) secondary dementia (3): I Primary degenerative deme ...
... minor damage in these areas can cause dementia, but also larger impairments in other parts of the brain can lead to dementia (3). Dementia can be divided in three main groups by it's cause: I) primary degenerative dementia II)vascular dementia III) secondary dementia (3): I Primary degenerative deme ...
The dilemma in the concept and the management of bipolar
... onset and offset, and seasonal depression, even without discernible hypomanic episodes [5]. Some bipolar disorder II features are more prevalent than bipolar disorder I in the community. It is frequently misdiagnosed as recurrent major depression (from 27 to 65% of patients with this diagnosis are r ...
... onset and offset, and seasonal depression, even without discernible hypomanic episodes [5]. Some bipolar disorder II features are more prevalent than bipolar disorder I in the community. It is frequently misdiagnosed as recurrent major depression (from 27 to 65% of patients with this diagnosis are r ...
Name Removed ENGL 101, Sect. 0202 Prof. Thomas Geary August
... associated with antipsychotic medications would significantly disrupt normal development and put the child at a disadvantage for the rest of his or her life. Given all of the dangers associated with antipsychotic medications, there has to be some reason why they are prescribed to children in such in ...
... associated with antipsychotic medications would significantly disrupt normal development and put the child at a disadvantage for the rest of his or her life. Given all of the dangers associated with antipsychotic medications, there has to be some reason why they are prescribed to children in such in ...
The Early Diagnosis and Management of Psychosis
... Psychosis is the term used to describe a mental state in which the individual experiences a distortion or loss of contact with reality, without clouding of consciousness. This mental state is characterised by the presence of delusions, hallucinations and/or thought disorder. As well as these so call ...
... Psychosis is the term used to describe a mental state in which the individual experiences a distortion or loss of contact with reality, without clouding of consciousness. This mental state is characterised by the presence of delusions, hallucinations and/or thought disorder. As well as these so call ...
olanzapine - PsychSearch
... olanzapine 5 milligrams (mg) daily to a stable dose of clozapine (Henderson et al, 1998). Olanzapine is increased by 2.5 to 5 mg weekly to a maximum of 30 mg/day. After the first week, clozapine doses should be gradually decreased by increments of 25 to 50 mg per week. 2) Switching patients to olanz ...
... olanzapine 5 milligrams (mg) daily to a stable dose of clozapine (Henderson et al, 1998). Olanzapine is increased by 2.5 to 5 mg weekly to a maximum of 30 mg/day. After the first week, clozapine doses should be gradually decreased by increments of 25 to 50 mg per week. 2) Switching patients to olanz ...
PROPOSAL FOR THE INCLUSION OF RISPERIDONE FOR THE
... June 29, 2004. Teva Pharmaceuticals was the first company to gain FDA approval for a generic form of Risperidone in June 2008, and some sixteen companies would follow suit over the next three years. See Appendix A for a list of companies who currently have US FDA approval for a generic form of Rispe ...
... June 29, 2004. Teva Pharmaceuticals was the first company to gain FDA approval for a generic form of Risperidone in June 2008, and some sixteen companies would follow suit over the next three years. See Appendix A for a list of companies who currently have US FDA approval for a generic form of Rispe ...
Bipolar Disorders - Dr. Ron Remick`s website
... Quetiapine and Olanzepine show evidence of mood stabilizing properties – both antidepressant and antimanic. Current guidelines suggest Quetiapine is preferable to other antipsychotic agents due to its side effect profile. Olanzapine is a 3rd line treatment due to its side effect profile. Side effect ...
... Quetiapine and Olanzepine show evidence of mood stabilizing properties – both antidepressant and antimanic. Current guidelines suggest Quetiapine is preferable to other antipsychotic agents due to its side effect profile. Olanzapine is a 3rd line treatment due to its side effect profile. Side effect ...
Clinical Scholar Sample Packet
... Elderly: Effects on Cognition and Implications for Use. Drugs and Aging 2001; 18:45-61. Byerly M, Suppes T, Pikalov A, Baker R. Clinical Implications of Antipsychotic-Induced Hyperprolactinemia in Patients With Schizophrenia Spectrum or Bipolar Spectrum Disorders: Recent Developments and Current Per ...
... Elderly: Effects on Cognition and Implications for Use. Drugs and Aging 2001; 18:45-61. Byerly M, Suppes T, Pikalov A, Baker R. Clinical Implications of Antipsychotic-Induced Hyperprolactinemia in Patients With Schizophrenia Spectrum or Bipolar Spectrum Disorders: Recent Developments and Current Per ...
ASD and pscyhosis the overlap - Royal College of Psychiatrists
... place • treating co-morbidities may lead to better outcomes? Vs. Autism overshadowing other diagnoses ...
... place • treating co-morbidities may lead to better outcomes? Vs. Autism overshadowing other diagnoses ...
Olanzapine
Olanzapine (originally branded Zyprexa) is an atypical antipsychotic. It is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia and bipolar disorder.Olanzapine is structurally similar to clozapine and quetiapine, but is classified as a thienobenzodiazepine. The olanzapine formulations are manufactured and marketed by the pharmaceutical company Eli Lilly and Company; the drug went generic in 2011. Sales of Zyprexa in 2008 were $2.2B in the US, and $4.7B worldwide.